Hepion Pharmaceuticals Inc (NASDAQ:HEPA)
| 0.6788 BATS BZX Real-Time Price As of Mar 23 |  0.00 / 0.00%Today’s Change | 0.26 Today|||52-Week Range 1.33 | +126.04% Year-to-Date |
Latest HEPA News | Press Releases
No recent news for Hepion Pharmaceuticals Inc.
Today’s Trading
| Previous close | 0.68 |
| Today’s open | 0.68 |
| Day’s range | 0.68 - 0.69 |
| Volume | 727 |
| Average volume (3 months) | 593,060 |
| Market cap | $59.9M |
Data as of 3:51pm ET, 03/23/2023
Growth & Valuation
| Earnings growth (last year) | +77.87% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.66 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ONCTOncternal Therapeuti... | +0.00 | +0.05% |
| LOVFFCannara Biotech Inc | -0.03 | -4.33% |
| VIRXViracta Therapeutics... | +0.04 | +2.92% |
| ---- |
Data as of 1:02pm ET, 03/24/2023
Financials
| Next reporting date | May 16, 2023 |
| EPS forecast (this quarter) | -$0.15 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$32.7M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Edison, New Jersey |
Forecasts
